ARCHIVES

Sanofi Responds to Criticism From Oncologists

This article is from The Cancer Letter archive.

Vol. 38 No. 42 | November 8, 2012

Download PDF Visit The Full Archive

Related Articles

NCAB Committee Urged to Seek Surgical Oncology Certification

June 14, 1985

Smokers Quitlines Found Effective Regardless of Recruitment Method

June 24, 2011

National Coalition An Education Group, Chairman Says

May 3, 1985

Lilly drug Alimta misses the target, but wins ODAC endorsement for lung cancer. FDA’s Pazdur tells ODAC that decision on Alimta requires clinical judgment.

July 30, 2004

Conversation With The Cancer Letter: PanCAN CEO Denies Bill Would Undermine NCI’s Role in Directing and Funding Research

August 3, 2012

Letter to The Editor: IOM Panel Urges Greater Integration Of Research

February 12, 1999